Premier Fund Managers LTD Maxcyte, Inc. Transaction History

Premier Fund Managers LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$3.02 - $5.1 $218,427 - $368,867	-72,327 Reduced 66.89%	35,800 $113,000
Q2 2023 Aug 03, 2023	SELL	$3.69 - $5.35 $283,189 - $410,585	-76,745 Reduced 41.51%	108,127 $485,000
Q1 2023 May 05, 2023	SELL	$4.03 - $5.89 $284,207 - $415,380	-70,523 Reduced 27.61%	184,872 $868,000
Q4 2022 Feb 09, 2023	BUY	$4.92 - $7.4 $1.07 Million - $1.6 Million	216,695 Added 559.94%	255,395 $1.37 Million
Q4 2022 Feb 08, 2023	SELL	$4.92 - $7.4 $1.07 Million - $1.6 Million	-216,695 Reduced 84.85%	38,700 $2.73 Million

Q3 2022 Nov 04, 2022	BUY	$4.52 - $6.51 $1.15 Million - $1.66 Million	255,395 New	255,395 $1.61 Million

126

62M

2.4K

2.1K

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $412M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

Stay updated on Premier Fund Managers LTD with notifications on news.